Jump to content
Sign in to follow this  

Alkini Approved by NHS Scotland


ADSHG

  • The Scottish Medicines Consortium has approved Alkini (hydrocortisone granules in capsule form) for restricted use in NHS Scotland. Following a submission by ADSHG, the SMC said "We would like to thank you for the time and effort taken to produce your submission. Capturing the views and experiences of patients and carers is an important part of the SMC process and plays a key role in helping our Committee reach its decisions."

The SMC has accepted hydrocortisone granules for restricted use for the replacement therapy of adrenal insufficiency. This acceptance is limited to use in infants and young children aged from birth to less than six years old, where the only options to get the right dose are to break up and crush hydrocortisone tablets, produce special solutions or to use hydrocortisone buccal tablets (that dissolve when held between the gum and the cheek) that are not licensed (approved) for treating adrenal insufficiency.

 

The SMC have published the explanation for their decision, which is available for download from our website here : Decision explained hydrocortisone final.pdf.

 

Further details are available here : https://www.scottishmedicines.org.uk/medicines-advice/hydrocortisone-alkindi-fullsub-smc2088/

 



  Report Article
Sign in to follow this  



About us

The Addison’s Disease Self-Help Group is the support group for people with Addison’s disease or adrenal insufficiency and their families in the UK and Ireland.The group was formed in 1984 and is a UK registered charity no. 1106791.

Get in touch

    Our Online Volunteers

  • pippa sharman
    pippa sharman
  • vsadler
    vsadler
  • annelben
    annelben
  • frances1
    frances1
  • webmaster
    webmaster
  • suep1954
    suep1954
  • a5037847
    a5037847

A dedicated team of volunteers contribute to and support the website, forum, shop, publications centre, video hub plus social media engagement on behalf of the charity.

×

Important Information

By using this website you are consenting to the use of cookies. Details about their use and how you can adjust your cookie settings are described in our cookie statement.